MetLife, Inc.
NYSE:METInsurance - Life
-$0.15 today
- Market cap
- $62.71B
- Beta
- 0.78
- P/E (TTM)
- 15.4
- EPS (TTM)
- $5.55
- Dividend yield
- 2.68%
Volume 4.27M
Average 3.49M
MET EPS (Basic)
Net income attributable to common shareholders divided by the weighted average basic shares outstanding.
MetLife, Inc.NYSE: MET
EPS (Basic) · Q2 FY2026 · quarter ended Jun 2026
EPS (Basic) growth accelerates
Q2 FY2026 EPS (Basic) of $1.1 rose 5.8% year over year, ahead of the -11.6% change in trailing-twelve-month EPS (Basic). Sequentially, it fell 37.1% from the prior quarter. Over 3 fiscal years it compounded at -8.9% a year.
Context
- EPS (Basic) increased in 1 of the last 3 fiscal years.
What to watch
Whether EPS (Basic) reaches the consensus estimate from 10 analysts of $10.24 (+113.2%) for the fiscal year ending Dec 2026, a step up from the -19.7% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $1.1-37.1% QoQ
- Last fiscal yearDec 2025
- $4.8-19.7% YoY
- LTMJun 2026
- $5.25-11.6% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +5.8% | +125.5% | +119.7 pp |
| 1 year | -19.7% | +113.2% | +133.0 pp |
| 3-year CAGR | -8.9% | +37.1% | +46.0 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Basic) history
USD · from the income statement
- Latest · FY2025
- 4.80 USD
- Year-over-year change
- -19.7%
- 4-year CAGR
- -11.1%
| Period | Period end | EPS (Basic) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.80 | -19.7% |
| FY2024 | 2024-12-31 | 5.98 | +228.6% |
| FY2023 | 2023-12-31 | 1.82 | -71.3% |
| FY2022 | 2022-12-31 | 6.35 | -17.5% |
| FY2021 | 2021-12-31 | 7.70 | — |
EPS (Basic) vs competitors
How MET compares with its peers on the latest reported figures
- Peers report in different currencies, so EPS (Basic) is compared through growth and rates rather than absolute size.
- Its year-over-year change of -11.6% is the 8th highest of 11, against a peer median of +13.5%.
- Over three fiscal years its annual growth of -8.9% compares with a peer median of -4.8%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Sep 2026 | $18.58 USD | -14.8% | +22.9% | |
| LTM Sep 2026 | $15.22 USD | +9.9% | +16.1% | |
| LTM Jun 2026 | $12 USD | +100.7% | -9.2% | |
| LTM Jun 2026 | $11.15 USD | +146.1% | — | |
| LTM Sep 2026 | $10.04 USD | -31.8% | -51.8% | |
| LTM Jun 2026 | $9.32 USD | +109.8% | -0.5% | |
| LTM Jun 2026 | $5.97 USD | +17.1% | +10.7% | |
| LTM Jun 2026 | $5.25 USD | -11.6% | -8.9% | |
| LTM Jun 2026 | $4.29 USD | -48.8% | -15.2% | |
| LTM Jun 2026 | CA$3.69 CAD | +18.3% | — | |
| LTM Jun 2026 | $2.97 USD | +7.7% | -24.5% | |
| Peer median (excluding MET) | — | +13.5% | -4.8% | |
Competitors are the stored peer set for MET. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 63.37B | 67.97B | 67.71B | 69.94B | 77.08B |
| Cost of Revenue | 46.53B | 49.03B | 50.42B | 50.94B | 49.06B |
| Gross Profit | 16.84B | 18.94B | 17.29B | 19B | 28.02B |
| Gross Margin | 26.6% | 27.9% | 25.5% | 27.2% | 36.4% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 5.76B | 5.86B | 6.18B | 5.99B | 0 |
| Operating Expenses | 8.32B | 12.57B | 15.13B | 13.38B | 23.36B |
| Depreciation & Amortization | 694M | 673M | 718M | 714M | 753M |
| EBITDA | 10.13B | 7.98B | 3.93B | 7.37B | 6.48B |
| EBITDA Margin | 16.0% | 11.7% | 5.8% | 10.5% | 8.4% |
| Operating Income | 8.52B | 6.36B | 2.16B | 5.62B | 4.66B |
| Operating Margin | 13.4% | 9.4% | 3.2% | 8.0% | 6.0% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 920M | 938M | 1.05B | 1.04B | 1.06B |
| Other Income / Expenses | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | 8.52B | 6.36B | 2.16B | 5.62B | 4.66B |
| Pre-Tax Margin | 13.4% | 9.4% | 3.2% | 8.0% | 6.0% |
| Income Tax Expense | 1.64B | 1.06B | 560M | 1.18B | 1.26B |
| Net Income | 6.86B | 5.28B | 1.58B | 4.43B | 3.38B |
| Net Margin | 10.8% | 7.8% | 2.3% | 6.3% | 4.4% |
| EPS (Basic) | 7.70 | 6.35 | 1.82 | 5.98 | 4.80 |
| EPS (Diluted) | 7.65 | 6.30 | 1.81 | 5.94 | 4.80 |
| Weighted Avg Shares | 825.54M | 779.1M | 762.43M | 689.21M | 664.96M |
| Weighted Avg Shares (Diluted) | 869.4M | 808.9M | 762.43M | 711.1M | 664.96M |
MetLife, Inc.
NYSE:MET
Intrinsic Alpha fair value
Locked
Current Price
$99.79
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.